AD has been associated with many tau-related biomarkers [103]; for example, exosomes containing phosphorylated tau have been found in the cerebrospinal fluid (CSF) of early AD patients and the amount of tau protein in CSF can be correlated with the severity of cognitive impairment [104,105]. This evidence concerns the gene MAPT and Alzheimer disease.